| |
NewswireToday - /newswire/ -
Hemel Hempstead, Hertfordshire, United Kingdom, 03/19/2010 - Thermo Fisher Scientific Inc., the world leader in serving science, today announced it is providing the Scottish Metabolomics Facility (ScotMet) with cutting-edge technology to advance the field of metabolomics.
|
| |
ScotMet is funded by the Scottish Universities Life Science Alliance (SULSA) and is a state-of-the-art facility run jointly by the Universities of Glasgow and Strathclyde. The facility combines mass spectrometry, separations technology and bioinformatics. ScotMet, which already used Thermo Fisher instruments, will now install four Thermo Scientific mass spectrometers, including an LTQ Orbitrap Velos with ETD and FAIMS source, a DSQ-II GC/MS and two Exactive LC/MS benchtop instruments.
The superior mass accuracy and sensitivity of the LTQ Orbitrap Velos, equipped with the multiple fragmentation modes available (CID, HCD, ETD and PQD), will allow researchers to rapidly accelerate their research. In addition, for high throughput metabolite screening experiments, the fast polarity switching of the Exactive allows effective data collection in positive and negative modes.
ScotMet is run by Dr Karl Burgess at the University of Glasgow. According to Dr Burgess, "Metabolomics allows us to understand relationships between the small molecules that drive biological systems, giving us insights into cancer and other serious illnesses. ScotMet had already implemented a Thermo Scientific LTQ Orbitrap and following the success of this instrument, we looked to Thermo Fisher Scientific to provide additional instrumentation."
Dr. Dave Watson at the University of Strathclyde stated: "We've had excellent results over the past three years of undertaking metabolomics experiments with the Thermo Scientific LTQ Orbitrap, and the addition of the LTQ OT Velos, Exactives and GC/MS capability will expedite existing projects and extend the range of important biological and medical problems with which we can work."
The executive director of SULSA, Dr. Jennifer Bell, explained, "Metabolomics is important to systems biology and systems medicine. ScotMet aims to provide a world-class facility staffed by experts in metabolomics who work closely with leaders in the fields of genomics, proteomics and bioinformatics to offer training, sample analysis and collaboration on experimental design and data handling. This advances the growing field of metabolomics and to support systems initiatives across Scotland."
Thermo Scientific is part of Thermo Fisher Scientific, the world leader in serving science.
About Thermo Fisher Scientific
Thermo Fisher Scientific Inc. (NYSE: TMO) is the world leader in serving science. Our mission is to enable our customers to make the world healthier, cleaner and safer. With revenues of more than $10 billion, we have approximately 35,000 employees and serve customers within pharmaceutical and biotech companies, hospitals and clinical diagnostic labs, universities, research institutions and government agencies, as well as in environmental and process control industries. We create value for our key stakeholders through two premier brands, Thermo Scientific and Fisher Scientific, which offer a unique combination of continuous technology development and the most convenient purchasing options. Our products and services help accelerate the pace of scientific discovery, and solve analytical challenges ranging from complex research to routine testing to field applications.
For further press information please contact: Laura Browne, The Scott Partnership, 1 Whiteside, Station Road, Holmes Chapel, Cheshire CW4 8AA, United Kingdom T: +44 1477 539539 F: +44 1477 539 540 E: thermo[.]scottpr.com.
|
analyze[.]thermofisher.com 
